News from CNBC Business

All U.S. UK Canada Australia India Global Global (Crypto)

What is your interest today?

Bitcoin Crypto Btc Ceo Tariffs Stocks Investors Crypto Assets Shares Cryptocurrency Stock Stock Market Ethereum Price Markets Xrp Investment Blockchain Etf Stablecoin Sec Eth Bse Trade Ipo Index Solana Earnings Revenue China Coinbase Inflation Token Wall Street Nasdaq Interest Rates Sensex Gold Usd Trade War Nse Traders Economy Treasury Tesla Profit Federal Reserve Bse Sensex Digital Assets Sp 500 Tencent Patent Infringement Institutional Flows Asa Prison Golf Course Trade Show Bipartisan Bill Financial Loss Central Reserves

Filter by:

Eli Lilly × CNBC Business ×

CNBC Business • May 21, 2025

Cigna announces new deal for copay caps on Eli Lilly and Novo Nordisk weight loss drugs

Cigna’s Evernorth division reached an agreement that aims to reduce out-of-pocket expenses for employers and employees on certain weight management medications from Eli Lilly and N...

Read Full Article →

CNBC Business • May 19, 2025

Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli Lilly

Novo Nordisk’s leadership change aims to strengthen its position in the weight loss market, improve competitive standing against Eli Lilly, and address upcoming industry challenges...

Read Full Article →

CNBC Business • May 01, 2025

Eli Lilly sales soar 45% on weight loss drug demand, but drugmaker cuts profit outlook after cancer...

Eli Lilly experienced a significant increase in sales attributed to strong demand for its weight loss and diabetes medications, yet adjusted its profit forecast following a recent...

Read Full Article →